MRM SCHEDULE 13G/A: SEC filing
Filed with the SEC on · accession 0002045681-26-000003
MRM filed a SCHEDULE 13G/A (schedule 13g/a) with the SEC on Nov 16, 2026. Triple One Investment Partnership, Kabushiki Kaisha CARPE DIEM, and Takao Shimura filed an amended Schedule 13G reporting beneficial ownership of 66,540 American Depositary Shares of Medirom Healthcare Technologies, representing 0.8% of the outstanding shares. The stock moved +1.2% by the first close after the filing.
Summary of the filing
Triple One Investment Partnership, Kabushiki Kaisha CARPE DIEM, and Takao Shimura filed an amended Schedule 13G reporting beneficial ownership of 66,540 American Depositary Shares of Medirom Healthcare Technologies, representing 0.8% of the outstanding shares. The filing notes that following the cancellation of a convertible bond, no shares issuable upon conversion are included in the calculation.
Key details
How MRM stock reacted
Close before
$0.28
Nov 13, 2026
First close after
+1.16%
$0.28
5 trading days
—
Since filing
—
✦ Ask GOAX AI about this filing — what it means for MRM, what changed since its last filings and what to watch next.
Try it free for 7 days🔔 Want to stay updated on new SEC filings for MRM?
Click hereFrequently asked questions
What did MRM file with the SEC on Nov 16, 2026?
MRM filed a SCHEDULE 13G/A (SEC filing). Triple One Investment Partnership, Kabushiki Kaisha CARPE DIEM, and Takao Shimura filed an amended Schedule 13G reporting beneficial ownership of 66,540 American Depositary Shares of Medirom Healthcare Technologies, representing 0.8% of the outstanding shares. The filing notes that following the cancellation of a convertible bond, no shares issuable upon conversion are included in the calculation.
How do I read a SCHEDULE 13G/A?
A report the company filed with the SEC (the US market regulator). Start with the summary, then the key amounts and names. Compare it with the company’s earlier filings.
Why are SEC filings important?
Public companies must tell the SEC about anything that can change their value — results, leadership changes, big deals, new shares, bankruptcy. Filings are the official source, often before the news. A SCHEDULE 13G/A (schedule 13g/a): A report the company filed with the SEC (the US market regulator).
How did MRM stock react to this filing?
MRM closed at $0.28 before the filing and $0.28 on Nov 16, 2026 (+1.16%).
Other MRM SEC filings
- 6-K · Delisting noticeOct 13, 2026
- SCHEDULE 13D/A · Activist campaignAug 28, 2026
- 6-K · SEC filingAug 27, 2026
- 6-K · SEC filingAug 27, 2026
- 6-K · Material agreementAug 7, 2026
- 6-K · Late filingAug 7, 2026
- 6-K · Contract winJun 25, 2026
- 6-K · Delisting noticeMay 29, 2026
- 6-K · SEC filingMay 28, 2026
- 6-K · SEC filingApr 22, 2026
Get alerts when MRM files with the SEC, plus live charts, key levels and news for 13,000+ stocks.
Try SEPT free for 7 days